Oruka Therapeutics, Inc. (ORKA)

SEC filing

Oruka Therapeutics, Inc.

ORKA · CIK 907654

4 · Sep 15, 2026 · General Counsel Quinlan Paul T sold 1,039 shares at $95.71/share ($99,443)

General Counsel Quinlan Paul T sold 1,039 shares at $95.71/share ($99,443)

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).

4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESform4.xml
Open SEC.gov